The University of Chicago Header Logo

Connection

Mark Kozloff to Inflammation

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Inflammation.
Mark Kozloff
Connection Strength
0.024
Inflammation
  1. TGFß receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer. Cancer Chemother Pharmacol. 2019 05; 83(5):975-991.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.